Miikka. Vikkula (@miikkavikkula) 's Twitter Profile
Miikka. Vikkula

@miikkavikkula

ID: 868462958749388800

linkhttps://www.deduveinstitute.be/human-genetics calendar_today27-05-2017 13:44:39

552 Tweet

664 Followers

306 Following

F.R.S.-FNRS (@frsfnrs) 's Twitter Profile Photo

Le Prix international Gagna & Van Heck pour les maladies incurables décerné à Laurence Boon et Miikka. Vikkula @UCLouvain_be pour leurs travaux sur les anomalies vasculaires. de Duve Institute Cliniques universitaires Saint-Luc WEL Research Institute Véronique Halloin ➕ Communiqué : frs-fnrs.be/docs/Prix/Gagn…

Le Prix international Gagna &amp; Van Heck pour les maladies incurables décerné à <a href="/LaurenceBoon1/">Laurence Boon</a>  et <a href="/MiikkaVikkula/">Miikka. Vikkula</a> @UCLouvain_be pour leurs travaux sur les  anomalies vasculaires. <a href="/deDuveInstitute/">de Duve Institute</a> <a href="/ClinUnivStLuc/">Cliniques universitaires Saint-Luc</a> <a href="/WELRI_asbl/">WEL Research Institute</a> <a href="/VHalloin/">Véronique Halloin</a> 
➕ Communiqué : frs-fnrs.be/docs/Prix/Gagn…
NAVBO (@vascularbiology) 's Twitter Profile Photo

#NAVBO Member Publication Alert Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema Dr. Kari Alitalo & Miikka Vikkula groups Journal of Clinical Investigation 2024 Pascal Brouillard - UCLouvain Miikka. Vikkula jci.org/articles/view/…

#NAVBO Member Publication Alert

Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema

Dr. Kari Alitalo &amp; Miikka Vikkula groups <a href="/jclinicalinvest/">Journal of Clinical Investigation</a> 2024 <a href="/Pasc_Brouillard/">Pascal Brouillard - UCLouvain</a> <a href="/MiikkaVikkula/">Miikka. Vikkula</a>
jci.org/articles/view/…
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

World Fédération of Interventional and Therapeutic Neuroradiology (⁦WFITN 2024 NEW YORK CITY⁩ ) with a Great single speaker session by Pr Laurence Boon from ⁦Cliniques universitaires Saint-Luc⁩ on Medical Management of #vascular #anomalies. Great discussion! #vascapa ⁦VASCERN⁩ ⁦HEVAS

World Fédération of Interventional and Therapeutic Neuroradiology (⁦<a href="/wfitn_ny/">WFITN 2024 NEW YORK CITY</a>⁩ ) with a Great single speaker session by Pr Laurence Boon from ⁦<a href="/ClinUnivStLuc/">Cliniques universitaires Saint-Luc</a>⁩ on Medical Management of #vascular #anomalies. Great discussion! #vascapa ⁦<a href="/vascern/">VASCERN</a>⁩ ⁦<a href="/hevas_nl/">HEVAS</a>⁩
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

Abstract submission dead-line for #VAC2025 fast approaching (lnkd.in/ee8K_374) ! Don’t miss the opportunity to share your work in this unique meeting combining basic science with translational studies and clinical trials! VASCERN #vascapa, #evbo NAVBO, HEVAS CMTC-OVM

Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

Abstract submission dead-line for VAC 2025 (lnkd.in/ee8K_374) extended until Sunday 20th October. We look forward to seeing yours! This will be another exciting meeting bringing together clinicians and basic scientists to develop novel #therapies for vascular anomalies.

Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

The 2024 #ASHG Denver Colorado 2nd be last day started. Amazing how technology continues to progress enabling us to study even better pathophysiology of #rare and common #diseases. ⁦VASCAPA_asbl⁩ ⁦VASCERN⁩ ⁦HEVAS⁩ ⁦EURORDIS-Rare Diseases Europe⁩ ⁦⁦Leducq Vascular Malformations Network

The 2024 #ASHG Denver Colorado 2nd be last day started. Amazing how technology continues to progress enabling us to study even better pathophysiology of #rare and common #diseases. ⁦<a href="/VASCAPA/">VASCAPA_asbl</a>⁩ ⁦<a href="/vascern/">VASCERN</a>⁩ ⁦<a href="/hevas_nl/">HEVAS</a>⁩ ⁦<a href="/eurordis/">EURORDIS-Rare Diseases Europe</a>⁩ ⁦⁦<a href="/Leducq_ReVAMP/">Leducq Vascular Malformations Network</a>⁩
JTH (@jthjournal) 's Twitter Profile Photo

Check out the therapeutic algorithm for managing vascular malformations, as proposed by Miikka. Vikkula in our #November issue! This recent review offers valuable guidance for clinicians tackling these complex cases. Read more at jthjournal.org/article/S1538-…

Check out the therapeutic algorithm for managing vascular malformations, as proposed by <a href="/MiikkaVikkula/">Miikka. Vikkula</a> in our #November issue! This recent review offers valuable guidance for clinicians tackling these complex cases.

Read more at jthjournal.org/article/S1538-…
🎗️Karina Yaniv🎗️ (@karinayaniv) 's Twitter Profile Photo

📢Vessels aficionados📢The program of the #GRC_Angiogenesis2025 is up!! Fantastic speakers from different worlds- immunology, cancer, neuro, stem cells, etc- will tell us how vessels interact with their neighboring cells! Apply quickly! 20+ talks from selected abstracts! Link 👇

📢Vessels aficionados📢The program of the  #GRC_Angiogenesis2025 is up!! Fantastic speakers from different worlds- immunology, cancer, neuro, stem cells, etc- will tell us how vessels interact with their neighboring cells! Apply quickly! 20+ talks from selected abstracts! Link 👇
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

Abstract selection for #VAC2025 finished. You now have until Sunday November 24th (midnight) to register with the early-bird prize!! vacure-conference.net #vascapa #hevas #cmtc NAVBO VASCERN ISSVA EVBO

Abstract selection for #VAC2025 finished. You now have until Sunday November 24th (midnight) to register with the early-bird prize!!  vacure-conference.net #vascapa #hevas #cmtc <a href="/vascularbiology/">NAVBO</a>  <a href="/vascern/">VASCERN</a> <a href="/ISSVA_org/">ISSVA</a> <a href="/EVB_Org/">EVBO</a>
VASCERN (@vascern) 's Twitter Profile Photo

🩺Kaposiform Hemangioendothelioma (KHE) is rare, but expert #care shouldn’t be. Our new patient pathway provides step-by-step guidance for #diagnosis & #treatment to improve care outcomes. 👉 Access now: bit.ly/KHEpathway #RareDisease #VascularHealth #PatientCare

🩺Kaposiform Hemangioendothelioma (KHE) is rare, but expert #care shouldn’t be. Our new patient pathway provides step-by-step guidance for #diagnosis &amp; #treatment to improve care outcomes. 

👉 Access now: bit.ly/KHEpathway
#RareDisease #VascularHealth #PatientCare
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

Our latest educational review is now published in Hematology (ashpublications.org/hematology/art…) Molecular landscape and classification of vascular anomalies. I hope you find it useful. VASCAPA_asbl HEVAS CMTC-OVM VASCERN ISSVA EVBO NAVBO Leducq Vascular Malformations Network

Our latest educational review is now published in Hematology (ashpublications.org/hematology/art…)
Molecular landscape and classification of vascular anomalies. I hope you find it useful. <a href="/VASCAPA/">VASCAPA_asbl</a> <a href="/hevas_nl/">HEVAS</a> <a href="/CMTCOVM/">CMTC-OVM</a> <a href="/vascern/">VASCERN</a> <a href="/ISSVA_org/">ISSVA</a> <a href="/EVB_Org/">EVBO</a> <a href="/vascularbiology/">NAVBO</a> <a href="/Leducq_ReVAMP/">Leducq Vascular Malformations Network</a>
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

#VAC2025 is approaching. The exciting program will be online 2025. Look for intense discussions with numerous colleagues and company sponsors that are also present. Lots of interest in developing drug therapies for vascular anomalies. VASCERN VASCAPA_asbl CMTC-OVM HEVAS

#VAC2025 is approaching. The exciting program will be online 2025. Look for intense discussions with numerous colleagues and company sponsors that are also present. Lots of interest in developing drug therapies for vascular anomalies. 
<a href="/vascern/">VASCERN</a> <a href="/VASCAPA/">VASCAPA_asbl</a>  <a href="/CMTCOVM/">CMTC-OVM</a>  <a href="/hevas_nl/">HEVAS</a>
Miikka. Vikkula (@miikkavikkula) 's Twitter Profile Photo

International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : lnkd.in/e6_BbzQF. Congress networking dinner nearly sold out! Few seats left for congress participation. lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA

International Conference on Vascular Anomalies: Translating basic research into new therapies (VAC 2025)! : lnkd.in/e6_BbzQF. Congress networking dinner nearly sold out! Few seats left for congress participation.  lnkd.in/dzTfFVej #VASCAPA #HEVAS #CMTC #EVBO #ISSVA
Filière TETECOU (@filieretetecou) 's Twitter Profile Photo

🧪 [Journée '#Recherche et Innovation'] Venez écouter et échanger avec le Pr Miikka. Vikkula au sujet des anomalies vasculaires. 📆7 mars 2025 📌 Institut Imagine ✍🏼 inscription jusqu'au 23 février 👉🏽bit.ly/4eXmdYQ #maladiesrares 👇🏽

🧪 [Journée '#Recherche et Innovation']
Venez écouter et échanger avec le Pr <a href="/MiikkaVikkula/">Miikka. Vikkula</a>  au sujet des anomalies vasculaires.
📆7 mars 2025
📌 <a href="/InstitutImagine/">Institut Imagine</a> 
✍🏼 inscription jusqu'au 23 février
👉🏽bit.ly/4eXmdYQ
#maladiesrares
👇🏽
Lars Løkke Rasmussen (@larsloekke) 's Twitter Profile Photo

Dear American friends. We agree that status quo in the Artcic is not an option. So let’s talk about how we can fix it - together. Lars Løkke Rasmussen Danish Foreign Minister